# A Study of PF-07258669 In Healthy Adult Participants

> **NCT05113940** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 120 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-07258669
- **DRUG:** Placebo
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05113940
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-08
- **Primary completion:** 2023-07-27
- **Final completion:** 2023-07-27
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05113940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05113940, "A Study of PF-07258669 In Healthy Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05113940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*